Would Big Pharma Pay for the Wall?

France Nouvelles Nouvelles

Would Big Pharma Pay for the Wall?
France Dernières Nouvelles,France Actualités
  • 📰 WSJ
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

The government shutdown over funding for the border wall may start to put a dent in the prodigious cash flows of big drug and biotech firms

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

WSJ /  🏆 98. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

A Big, Fatty Opportunity for Big PharmaA Big, Fatty Opportunity for Big PharmaThe next multibillion-dollar therapeutic area for drug companies may be fatty liver disease, but there are a few practical hurdles to overcome first.
Lire la suite »

Samsung Faces Resistance From Big Pharma in the U.S.Samsung Faces Resistance From Big Pharma in the U.S.Samsung’s foray into the U.S. biologic-drug market is proving tougher than expected, as the South Korean company faces strong resistance from established pharmaceutical companies while doctors and patients are reluctant to switch to biosimilars.
Lire la suite »

Posh And Purposeful: The Hottest Luxury Cars For 2019 Are Pickup TrucksPosh And Purposeful: The Hottest Luxury Cars For 2019 Are Pickup TrucksBig pickups mean big profits for automakers, especially the current crop of luxury-equipped haulers that start in the $50,000 range and can extend well beyond $60,000 and even $70,000 when fully loaded.
Lire la suite »

The Exchange: Big Weed's big yearThe Exchange: Big Weed's big yearListen: Bruce Linton runs the world's biggest cannabis producer, Canopy Growth. He visited Breakingviews to discuss what's coming down the pipe in 2019, why a $100 bln weed company is still some way off, and why he doesn't actually partake - yet.
Lire la suite »

From Amgen to Gilead, drugmakers are sitting on billions of cash — and top pharma executives are hinting about big M&A to come in 2019From Amgen to Gilead, drugmakers are sitting on billions of cash — and top pharma executives are hinting about big M&A to come in 2019Billion-dollar deals from drug giants Eli Lilly & Co. and Bristol-Myers Squibb could set the tone for a year full of healthcare acquisitions.
Lire la suite »

Sen. Bernie Sanders says 'we will end' Big Pharma 'greed' in legislative push to cut drug pricesSen. Bernie Sanders says 'we will end' Big Pharma 'greed' in legislative push to cut drug pricesThe bills, led by Sanders and Reps. Elijah Cummings and Ro Khanna, would permit Health and Human Services Secretary Alex Azar to negotiate lower prices for drugs under Medicare Part D, the federal program for prescription drug benefits.
Lire la suite »



Render Time: 2025-03-23 04:03:47